Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGELESS: Aliskiren vs Ramipril in Elderly Systolic Hypertension
NCT00368277Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2006
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aliskiren in isolated systolic hypertension (ISH), sponsored by Novartis. Started Sep 2006; status: completed.
02
Drugs
aliskiren
03
Conditions
isolated systolic hypertension (ISH)
Beyond the preview
Go deeper on NCT00368277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00368277.